Source: PR Newswire

Press Release: SW Asset Management : Ronin Trading and SW Investment Management Respond to Recent Announcements by Peregrine Pharmaceuticals

CHICAGO, Aug. 14, 2017 /PRNewswire/ -- Ronin Trading, LLC and SW Investment Management LLC (together with the other participants in their solicitation, "Ronin"), collectively the second largest stockholder of Peregrine Pharmaceuticals, Inc. ("Peregrine" or the "Company") (NASDAQ:PPHM),...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100